Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical trials of biosimilars should become more similar.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical trials of biosimilars should become more similar.
Kay J, Isaacs JD. Clinical trials of biosimilars should become more similar. Ann Rheum Dis. 2017 01; 76(1):4-6.
View in:
PubMed
subject areas
Antirheumatic Agents
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Infliximab
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD